AT167629T

Sustained release pharmaceutical composition

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

27 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims1

Priority claims
Document	Office	Kind	Date
PJ219289	Australia	A	1989-01-06

Members27

Family members, oldest first
Document	Office	Kind
CA2007181A1	Canada	A1	1990-07-06
EP0377518A2	European Patent Office (EPO)	A2	1990-07-11
AU4773290A	Australia	A	1990-07-12
EP0377518A3	European Patent Office (EPO)	A3	1990-10-24
JPH032114A	Japan	A	1991-01-08
AU617573B2	Australia	B2	1991-11-28
NZ232029A	New Zealand	A	1992-04-28
US5202128A	United States of America	A	1993-04-13
US5330766A	United States of America	A	1994-07-19
EP0609961A1	European Patent Office (EPO)	A1	1994-08-10
US5378474A	United States of America	A	1995-01-03
EP0377518B1	European Patent Office (EPO)	B1	1996-02-07
AT133862T	Austria	T	1996-02-15
DE69025208D1	Germany	D1	1996-03-21
DE69025208T2	Germany	T2	1996-06-13
ES2085886T3	Spain	T3	1996-06-16
DK0377518T3	Denmark	T3	1996-06-24
GR3019201T3	Greece	T3	1996-06-30
HK154296A	Hong Kong, China	A	1996-08-16
EP0609961B1	European Patent Office (EPO)	B1	1998-06-24
AT167629TThis record	Austria	T	1998-07-15
DE69032445D1	Germany	D1	1998-07-30
ES2120562T3	Spain	T3	1998-11-01
CA2007181C	Canada	C	1998-11-24
DE69032445T2	Germany	T2	1999-02-18
DK0609961T3	Denmark	T3	1999-04-06
JP2937376B2	Japan	B2	1999-08-23

3 legal events, as the office reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code
2010-04-15	Cancelled due to lapse of timeLapsedEELA	EELA
2007-02-15	Change of the company nameEEFA	EEFA
1999-07-15	Publication of translation of european patent specificationUEP	UEP